FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel-L, Confirms 12-Month Reduction in Back Pain Supports Product Efficacy Approval Label May Include Opioid Reduction GlobeNewswire January 19, 2026 NEW YORK, Jan. 18, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided feedback received from the U.S. […]

WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced that it has been recognized on the “A List” for leadership in corporate transparency and performance across both Climate Change and Water Security by CDP (Carbon Disclosure Project). This recognition, which represents CDP's highest rating in each category, underscores WuXi

New York, New York–(Newsfile Corp. – January 18, 2026) – IRAEmpire, a trusted independent source for financial insights and retirement-industry research, today announced the release of its 2026 Precious Metals Investment Report, featuring an in-depth review of Lear Capital, one of the nation’s most established gold and silver IRA providers. The report highlights Lear Capital’s

Elliott, the largest independent shareholder of Toyota Industries, believes the revised tender offer very significantly undervalues the Company and does not intend to tender its shares Elliott Investment Management L.P. and Elliott Advisors (UK) Limited (“Elliott”), which advise funds that together have a significant ownership stake in Toyota Industries Corporation (“Toyota Industries” or the “Company”),

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Coupang, Inc. ("Coupang" or the "Company") (NYSE:CPNG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. ("Agilon" or the "Company") (NYSE:AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Optimism for Future Generations Collapses Globally The 2026 Edelman Trust Barometer reveals grievance has devolved into insularity. Seven in 10 respondents report unwillingness or hesitance to trust someone with different values, approaches to social issues, backgrounds, or information sources. This insularity is highest in developed markets, including Japan (90 percent) and Germany (81 percent). It

New York, New York–(Newsfile Corp. – January 18, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of America’s Car-Mart, Inc. (NASDAQ: CRMT) resulting from allegations that America’s Car-Mart may have issued materially misleading business information to the investing public. SO WHAT:

New York, New York–(Newsfile Corp. – January 18, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public. SO WHAT:

New York, New York–(Newsfile Corp. – January 18, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Varonis Systems, Inc. (NASDAQ: VRNS) common stock between February 4, 2025 and October 28, 2025, both dates inclusive (the “Class Period”). A class